Revised Bill Gives US Firms Time to Cut Ties With China Biotechs
US lawmakers have revised an earlier bill restricting ties between domestic and Chinese biotechnology firms to give companies at home time until 2032 to follow through with the restrictions. “China has so much control of the market. We’ve got to start …